HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma.

Int J Cancer · 2026 · PMC13047246 · PMID 41589342

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

borderline significancep = 0.058so close (0.05 < p ≤ 0.1)

Although the FIGO stage showed the most robust association with patient outcomes ( p <.001 for both PFS and OS), HIF2A expression also exhibited an independent prognostic value, with borderline significance for OS ( p = 0.058 for OS).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.